Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
31
2018
Are Your Food Products in Compliance With the New Prop 65 Requirements? Polsinelli PC
Feb
28
2020
340B In The Spotlight – CMS 340B Acquisition Cost Survey Proposal & President’s Budget Polsinelli PC
Apr
18
2024
FDA Preemption of State Law for False Labeling Survives Appeal to Supreme Court Polsinelli PC
Jul
19
2022
SCOTUS 340B Decision Drives CMS to Restore Part B 340B Payments and Seek Comments on Remedies in the CY 2023 OPPS Proposed Rule Polsinelli PC
Dec
19
2022
340B Hospital Reimbursement Update – Underpayments and the Need to Act Now Polsinelli PC
May
18
2023
Third Party Administrator and Pharmacy Benefit Manager Licensing and Compliance Developments Polsinelli PC
Apr
15
2016
Grace Period Ends Soon for California Companies with Products Containing BPA Polsinelli PC
Dec
4
2018
Clarification of OSHA Rule Regarding Drug Testing and Safety Incentive Programs Polsinelli PC
Feb
12
2019
Update on Pending Legislation: Three New Bills Have the Potential to Affect Generic Pharmaceutical Companies Polsinelli PC
Aug
8
2023
Third Party Administrator & Pharmacy Benefit Manager 2023 Newsletter Polsinelli PC
Nov
6
2020
Federal Circuit Limits Venue for Hatch-Waxman Cases Polsinelli PC
Jan
23
2018
Final DOT Rule Brings Drug Testing Changes Polsinelli PC
Sep
24
2021
Safer Federal Workforce Task Force Publishes Guidance for Contractor COVID-19 Vaccine Mandate Polsinelli PC
Dec
3
2021
CMS Vaccine Requirement Suspended During Injunctions Polsinelli PC
Jul
27
2023
CMS Proposes Changes to Medicare Provider Enrollment Rules Polsinelli PC
Jul
18
2016
Comprehensive Addiction and Recovery Act: Addressing Opioid Crisis Polsinelli PC
Feb
20
2019
Are you on the Prop 65 “Bounty Hunter” Radar? Beware, Online Sale of Wine Into California Could Cost You $2500 a Pop! Polsinelli PC
Nov
30
2016
Pharmacy Benefit Managers Face New Licensing Requirements Polsinelli PC
Feb
14
2024
HHS Finalized Part 2 Revisions: What Has Changed? Polsinelli PC
Mar
19
2024
Behavioral Health M&A 2024 Legal Trends Polsinelli PC
Aug
6
2019
CMS Takes Bold Action on Price Transparency & Physician Supervision in CY 2020 OPPS Proposed Rule Polsinelli PC
Jan
18
2023
What’s Old Is New Again: Reviving “Fairness” With Renewed FTC Price Discrimination Enforcement And What That Means For Companies Polsinelli PC
Dec
10
2019
Vermont Regulatory Action: A Reminder that Insurers Must Maintain Oversight of their TPA and PBM Business Partners Polsinelli PC
Jul
26
2017
Massachusetts Employers May Need to Accommodate Medical Marijuana Users Polsinelli PC
May
4
2023
DEA to Extend Current Telemedicine Flexibilities Polsinelli PC
Feb
6
2024
New SAMHSA Rule Expands Access to Medications for the Treatment of Opioid Use Disorder Polsinelli PC
Apr
19
2024
HRSA Aims for Swift Dispute Resolution with new 340B ADR Final Rule Polsinelli PC
Feb
22
2021
The Federal Circuit Raises the Enablement Bar for Antibody Patents Polsinelli PC
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins